A detailed history of Atria Investments LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Atria Investments LLC holds 849 shares of UTHR stock, worth $306,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
849
Previous 1,199 29.19%
Holding current value
$306,378
Previous $381,000 20.21%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$311.04 - $363.55 $108,864 - $127,242
-350 Reduced 29.19%
849 $304,000
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $273,683 - $382,528
1,199 New
1,199 $381,000
Q2 2019

Aug 09, 2019

BUY
$76.06 - $120.81 $325,004 - $516,221
4,273 New
4,273 $391,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.